DENVER–(BUSINESS WIRE)–Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, is scheduled to report fourth quarter and full year 2024 financial results after the close of trading on the New York Stock Exchange on Monday, February 3, 2025. Healthpeak will host a conference call and webcast on Tuesday, February 4, 2025, at 8:00 a.m. Mountain Time (10:00 a.m. Eastern Time) to review its financial performance and op

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today reported financial results for its first quarter fiscal 2025, ended November 30, 2024. First Quarter 2025 Financial Highlights (compared to first quarter 2024) Total revenue increased 31% to $18.9 million Software revenu

BILLERICA, Mass.–(BUSINESS WIRE)—- $BRKR #BRKR–Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 43rd annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO, Mark Munch, Executive Vice President & President of Bruker Nano Group, and Gerald Herman, Executive Vice President & CFO will present on behalf of the Company on Monday, January 13th, 2025 at 3:45 PM Pacific Standard Time. A live audio webcast of the presentation will

Redwood City, Kalifornien, und Venlo, Niederlande–(BUSINESS WIRE)–QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat heute eine Partnerschaft mit Genomics England bekannt gegeben, um die Durchführung der Generation Study zu unterstützen. Ziel dieser einzigartigen Initiative ist es, die Genome von 100.000 Neugeborenen in England zu sequenzieren. Damit sollen über 200 ausgewählte Erkrankungen frühzeitig erkannt und seltene Krankheiten schneller behandelt werden. Mithilfe seiner Clinical Kno

REDWOOD CITY, Calif. & VENLO, The Netherlands–(BUSINESS WIRE)–QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has partnered with Genomics England to support the delivery of the Generation Study. This first-of-its-kind initiative aims to sequence the genomes of 100,000 newborns in England to screen for over 200 selected conditions, enabling earlier diagnosis and treatment of rare conditions. Through its Clinical Knowledge Base, QIAGEN will be the only company to prov

MARLBOROUGH, Mass.–(BUSINESS WIRE)—- $HOLX #JPMC25–Hologic to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

FREMONT, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported unaudited preliminary revenue for the fourth quarter and full year ended December 31, 2024 and preliminary cash balance. Preliminary Full Year 2024 Revenue Revenue of approximately $84.6 million for the full year of 2024 compared with $73.5 million for the full year of 2023, an increase of 15%, and above the company’s previous full year guidance range of $83.0

PHOENIX–(BUSINESS WIRE)–Colossal’s America’s Favorite Pet brings joy to animal lovers everywhere and reinforces its mission as a platform with purpose supporting PAWS.

BOSTON–(BUSINESS WIRE)–Commonwealth Care Alliance® (CCA), a mission-driven healthcare services organization that offers high-quality health plans and care delivery programs designed for individuals with the most significant needs, today announced that it has been recognized as a 2025 “Leader in LGBTQ+ Workplace Inclusion” by the Human Rights Campaign Foundation, earning a perfect score of 100% on their Corporate Equality Index (CEI). The Human Rights Campaign Foundation’s CEI is the premier n

SAN FRANCISCO–(BUSINESS WIRE)– #aihealthcare–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced significant milestones in its mission to transform healthcare delivery. In 2024, the company forged new partnerships with three of the largest, global pharmaceutical companies in the world, realizing a total of 10 partnerships with leading life science companies. Viz.ai expanded its reach to serve 1,700 hospitals with a broad user base that grew by more than 30%